Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
27.2M
-
Shares change
-
-528K
-
Total reported value, excl. options
-
$285M
-
Value change
-
-$5.5M
-
Number of buys
-
35
-
Number of sells
-
-27
-
Price
-
$10.50
Significant Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q3 2017
86 filings reported holding AVDL - AVADEL PHARMACEUTICALS - COM as of Q3 2017.
AVADEL PHARMACEUTICALS - COM (AVDL) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.2M shares
.
Largest 10 shareholders include DEERFIELD MANAGEMENT CO (3.66M shares), Broadfin Capital, LLC (3.57M shares), JANUS HENDERSON GROUP PLC (2.15M shares), ARMISTICE CAPITAL, LLC (1.69M shares), ACADIAN ASSET MANAGEMENT LLC (1.66M shares), PERCEPTIVE ADVISORS LLC (1.55M shares), MORGAN STANLEY (1.5M shares), DEUTSCHE BANK AG\ (1.11M shares), Stonepine Capital Management, LLC (985K shares), and BROWN CAPITAL MANAGEMENT LLC (877K shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.